Growth Metrics

Dexcom (DXCM) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to $2.1 billion.

  • Dexcom's Total Current Liabilities fell 2692.7% to $2.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.1 billion, marking a year-over-year decrease of 2692.7%. This contributed to the annual value of $2.1 billion for FY2025, which is 2692.7% down from last year.
  • Per Dexcom's latest filing, its Total Current Liabilities stood at $2.1 billion for Q4 2025, which was down 2692.7% from $3.3 billion recorded in Q3 2025.
  • Dexcom's Total Current Liabilities' 5-year high stood at $3.3 billion during Q3 2025, with a 5-year trough of $600.7 million in Q2 2021.
  • In the last 5 years, Dexcom's Total Current Liabilities had a median value of $1.7 billion in 2023 and averaged $1.7 billion.
  • In the last 5 years, Dexcom's Total Current Liabilities soared by 16215.91% in 2023 and then plummeted by 2692.7% in 2025.
  • Over the past 5 years, Dexcom's Total Current Liabilities (Quarter) stood at $720.8 million in 2021, then soared by 155.17% to $1.8 billion in 2022, then dropped by 15.4% to $1.6 billion in 2023, then soared by 88.43% to $2.9 billion in 2024, then dropped by 26.93% to $2.1 billion in 2025.
  • Its last three reported values are $2.1 billion in Q4 2025, $3.3 billion for Q3 2025, and $3.3 billion during Q2 2025.